Trial Profile
An Open, Single-center, Phase 1 Study to Evaluate Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cell in Erectile Dysfunction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Autologous mesenchymal stem cell therapy Pharmicell (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- Sponsors Pharmicell
- 14 Nov 2018 Status changed from active, no longer recruiting to completed.
- 05 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Jul 2016 Planned End Date changed from 1 May 2017 to 1 May 2018.